Neurocrine Biosciences Inc

Robeco Institutional Asset Management B.V. NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/23/2026

Shares

113,261

Value ($000)

16,064

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/23/2026	16,064	0.0%	113,261	12/31/2025
2025 Q3	10/22/2025	3,957	0.0%	28,185	9/30/2025
2025 Q2	7/18/2025	1,898	0.0%	15,098	6/30/2025
2025 Q1	4/23/2025	1,794	0.0%	16,220	3/31/2025
2024 Q4	1/23/2025	1,998	0.0%	14,634	12/31/2024
2024 Q3	10/29/2024	44,623	0.1%	387,282	9/30/2024
2024 Q2	7/23/2024	45,979	0.1%	333,981	6/30/2024
2024 Q1	4/24/2024	42,786	0.1%	310,225	3/31/2024
2023 Q4	2/14/2024	23,414	0.1%	177,699	12/31/2023
2023 Q3	10/24/2023	17,333	0.0%	154,067	9/30/2023
2023 Q2	7/24/2023	14,632	0.0%	155,163	6/30/2023
2023 Q1	5/4/2023	16,442	0.0%	162,439	3/31/2023
2022 Q4	2/7/2023	22,479	0.1%	188,204	12/31/2022
2022 Q3	12/1/2022	6,838	0.0%	64,378	9/30/2022
2022 Q2	12/1/2022	861	0.0%	8,830	6/30/2022
2022 Q1	12/1/2022	57	0.0%	610	3/31/2022
2021 Q4	12/1/2022	294	0.0%	3,448	12/31/2021
2021 Q3	12/1/2022	324	0.0%	3,382	9/30/2021
2021 Q2	12/1/2022	329	0.0%	3,382	6/30/2021
2021 Q1	12/1/2022	329	0.0%	3,382	3/31/2021
2020 Q4	12/1/2022	392	0.0%	4,091	12/31/2020
2020 Q3	1/19/2021	393	0.0%	4,091	9/30/2020
2020 Q2	1/19/2021	15	0.0%	127	6/30/2020
2020 Q1	1/19/2021	290	0.0%	3,356	3/31/2020
2019 Q4	1/19/2021	52	0.0%	485	12/31/2019